Cong Xu

Cong Xu

41 años
Health Technology
Consumer Services

Perfil

Cong Xu is currently Chairman at IMPACT Therapeutics, Inc. since 2020.
Dr. Xu is a Non-Executive Director at EdiGene Inc. since 2018 and at ImmuneOnco Biopharmaceuticals (Shanghai), Inc. since 2020.
Dr. Xu is a Director at Shanghai Kechow Pharma, Inc. and Shanghai Allist Pharmaceuticals Co., Ltd., both since 2024.
Formerly, Dr. Xu was a Director at Arrivent BioPharma, Inc. from 2022 to 2023.
Dr. Xu earned a doctorate from Clemson University in 2012, a doctorate from the University of British Columbia in 2018, and an undergraduate degree from Tongji Medical College of Huazhong University of Science & Technology in 2007.

Cargos activos de Cong Xu

EmpresasCargoInicio
IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC. Director/Miembro de la Junta 01/10/2020
IMPACT THERAPEUTICS, INC Presidente 01/07/2020
SHANGHAI ALLIST PHARMACEUTICALS CO., LTD. Director/Miembro de la Junta 26/11/2024
Director/Miembro de la Junta 12/07/2024
Director/Miembro de la Junta 01/01/2018

Antiguos cargos conocidos de Cong Xu.

EmpresasCargoFin
ARRIVENT BIOPHARMA, INC. Director/Miembro de la Junta 01/12/2023
Ver el detalle de la experiencia de Cong Xu.

Formación de Cong Xu.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

65

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas9

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology